Affordable Access

Access to the full text

Role of Immunocytochemistry in the Cytological Diagnosis of Pulmonary Tumors

Authors
  • Metovic, Jasna
  • Righi, Luisella
  • Delsedime, Luisa
  • Volante, Marco
  • Papotti, Mauro
Type
Published Article
Journal
Acta Cytologica
Publisher
S. Karger AG
Publication Date
Mar 15, 2019
Volume
64
Issue
1-2
Pages
16–29
Identifiers
DOI: 10.1159/000496030
PMID: 30878997
Source
Karger
Keywords
License
Green
External links

Abstract

Pulmonary cytology is a challenging diagnostic tool, and it is usually evaluated considering medical history and radiological findings in order to reach an accurate diagnosis. Since the majority of lung cancer patients have an advanced stage at diagnosis, a cytological specimen is frequently the only material available for diagnosis and further prognostic/predictive marker determination. Several types of specimens can be obtained from the respiratory system (including sputum, bronchoalveolar lavage, bronchial brushing, fine needle aspiration, and pleural fluid) with different technical preclinical management protocols and different diagnostic yields. Immunocytochemistry (ICC) has a pivotal role in the determination of diagnostic, prognostic, and predictive markers. Therefore, limited cytology samples are to be used with a cell-sparing approach, to allow both diagnostic ICC evaluation as well as predictive marker assessment by ICC or specific molecular assays. In this review, we describe the most common ICC markers used for the diagnosis and prognostic/predictive characterization of thoracic tumors in different cytological specimens.

Report this publication

Statistics

Seen <100 times